z-logo
open-access-imgOpen Access
The ATF6-Met[67]Val Substitution Is Associated With Increased Plasma Cholesterol Levels
Author(s) -
Steven J.R. Meex,
Daphna WeissglasVolkov,
Carla Kallen,
Donna J. Thuerauf,
Marleen M. J. van Greevenbroek,
Casper G. Schalkwijk,
Coen D.A. Stehouwer,
Edith J. M. Feskens,
Lonneke Heldens,
Torik Ayoubi,
Marten H. Hofker,
Bradly G. Wouters,
Robert Vlietinck,
Janet S. Sinsheimer,
MarjaRiitta Taskinen,
Johanna Kuusisto,
Markku Laakso,
Tjerk W.A. de Bruin,
Päivi Pajukanta,
Christopher C. Glembotski
Publication year - 2009
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.108.180240
Subject(s) - substitution (logic) , medicine , cholesterol , endocrinology , chemistry , computer science , programming language
Activating transcription factor 6 (ATF6) is a sensor of the endoplasmic reticulum stress response and regulates expression of several key lipogenic genes. We used a 2-stage design to investigate whether ATF6 polymorphisms are associated with lipids in subjects at increased risk for cardiovascular disease (CVD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom